Table 2 Differences in MVP and UK Biobank populations
| Â | UK Biobank | MVP |
|---|---|---|
age at enrollment (median [min-max]) | 58 [37–73] | 64 [18–110] |
% female/male | 54.4/45.6 | 9.2/90.8 |
% diabetes | 15.1% | 46.6% |
% hypertensive diseases | 37.0% | 69.5% |
% lipid disorders | 21.1% | 71.3% |
% testicular dysfunction | 0.1% | 2.9% |
% renal failure | 14.1% | 24.5% |
% liver disease | 5.1% | 19.7% |
